AscellaHealth
AscellaHealth
Specialty Pharmacy and Healthcare Services Organization
Specialty Pharmacy and Healthcare Services Organization
Located in Berwyn, Pennsylvania, AscellaHealth is a prominent entity in the global Specialty Pharmacy and Healthcare services industry, with additional facilities spread across the United States and Europe. This organization is dedicated to providing a diverse array of specialized, technology-driven pharmaceutical and medical management services tailored to meet the requirements of payers, providers, life sciences companies, and patients. The company is recognized for its patient-centered approach, underpinned by proprietary technology that fosters the creation of innovative programs and services. These initiatives focus on improving health outcomes and the quality of life for patients suffering from complex, chronic conditions or rare diseases that necessitate the use of specialty medications, including gene and cell therapies.
Dea Belazi, serving as CEO and Co-founder, has played a crucial role in molding AscellaHealth into a globally recognized provider of Healthcare & Specialty Pharmacy (S.P.) solutions. With a dedicated team of over 200 employees worldwide, the company delivers customized, cutting-edge solutions that enhance access to medications and optimize patient outcomes, particularly for individuals with specialty conditions or rare diseases. Leveraging his broad experience as a successful business leader and his clinical expertise as a Registered Pharmacist, Belazi has strategically guided the development of its comprehensive suite of services to support the unique demands of pharmaceutical manufacturers and other key industry players.
Bill Oldham, as Chairman, President, and Co-founder, has effectively utilized his extensive experience in fintech within the pharmacy benefit management (PBM) sector to elevate AscellaHealth's position in Specialty Pharmacy. His leadership has been pivotal in driving the company to achieve a remarkable 1556% revenue growth over four years, fueled by both organic growth and strategic acquisitions. Oldham has received numerous accolades for his contributions, including being named Philadelphia Business Journal's 2022 CFO of the Year and earning a spot as a Philadelphia Titan 100 in 2023 and 2024.
AscellaHealth employs a holistic strategy that merges clinical, financial, and technological resources to simplify access to specialty medications, thereby enhancing clinical outcomes and enriching the therapy experience for patients with chronic or complex conditions requiring specialty pharmaceuticals, cell, and gene therapies. The organization offers an extensive portfolio of services, including Pre-Commercialization and Market Access Solutions, Hub and Patient Support, Limited Distribution Drug Strategies, Proprietary Specialty Pharmacy and Infusion Network, Customized Clinical Programs, Technology-based Patient Engagement, Medical and Pharmacy Benefit Management, Drug Rebate Programs, and Real-Time Prescription Data and Analytics, all supported by its advanced technology platform.
As a primary launch partner, AscellaHealth supports life sciences companies in the commercialization of treatments for chronic, complex conditions. The company offers a full spectrum of services that aid these companies from the clinical trial phase through patient product transitions, including distribution, patient support, and detailed data analysis.
AscellaHealth delivers a comprehensive suite of services designed to optimize patient outcomes and manage healthcare costs for captives, self-insured entities, at-risk providers, PBMs, and regional health plans. The organization specializes in specialty and medical cost management, formulary and network design, custom clinical programs, and comprehensive data analysis.
AscellaHealth has garnered widespread acclaim as a leader in the specialty pharmacy and healthcare services sectors. It is recognized for its innovative approaches with multiple awards and accolades. These include being named one of the 2024 Top 10 Pharma & Life Science Solutions Providers and a top Pharmacy Management Solutions Provider by Health Tech Outlook in 2024.
Dea Belazi, the co-founder of AscellaHealth, has directed the company to significant industry success, securing numerous prestigious awards such as The Financial Times Fastest Growing Company and Deloitte Fast 500. Belazi is a well-regarded figure in Philadelphia's business community, earning accolades such as EY Entrepreneur of The Year® National Finalist and Titan 100. His educational credentials include a PharmD from the University of Rhode Island, a Master of Public Health from Johns Hopkins University, and a post-doctoral health outcomes research fellowship at Thomas Jefferson University.
Bill Oldham, co-founder, has utilized his extensive experience as an entrepreneur, investor, and consultant across various industries to shape AscellaHealth's strategic growth. His expertise in fintech, coupled with his leadership in developing two $100-million companies, has significantly influenced the company's trajectory within the PBM industry. Oldham began his career on Wall Street in financial services and had an extensive global operational background. He holds an MBA from Manchester Business School with a focus on entrepreneurship and venture finance and a Blockchain Technologies certification from MIT Sloan School of Management.